V. Sonninen

发表

Acid monoamine metabolites in the cerebrospinal fluid of patients with Parkinson's disease

U. Rinne, V. Sonninen, 1972, Neurology.

[Levodopa treatment in parkinsonism].

U. Rinne, V. Sonninen, T. Siirtola, 1971, Duodecim; laaketieteellinen aikakauskirja.

Plasma concentration of levodopa in patients with Parkinson's disease.

U. Rinne, V. Sonninen, T. Siirtola, 1973, European neurology.

Treatment of Parkinson's disease with l-DOPA and decarboxylase inhibitor

U. Rinne, V. Sonninen, T. Siirtola, 2004, Zeitschrift für Neurologie.

Brain catecholamines and their metabolites in Parkinsonian patients. Treatment with levodopa alone or combined with a decarboxylase inhibitor.

U. Rinne, V. Sonninen, 1973, Archives of neurology.

THE ACTIVATING EFFECT OF L‐DOPA TREATMENT ON SEXUAL FUNCTIONS AND ITS EXPERIMENTAL BACKGROUND

M. Hyyppä, U. Rinne, V. Sonninen, 1970, Acta neurologica Scandinavica.

L-Dopa treatment in Parkinson's Disease.

U. Rinne, V. Sonninen, T. Siirtola, 1970, European neurology.

Brain glutamic acid decarboxylase activity in Parkinson's disease.

P. Riekkinen, U. Rinne, V. Sonninen, 1974, European neurology.

Brain dopamine turnover and the relief of parkinsonism.

R. Marttila, U. Rinne, V. Sonninen, 1977, Advances in experimental medicine and biology.

RELATIONSHIP BETWEEN BRAIN DOPAMINE TURNOVER AND THE THERAPEUTIC RESPONSE TO BROMOCRIPTINE

R. Marttila, U. Rinne, V. Sonninen, 1979 .

Debrisoquine oxidation in Parkinson's disease

R. Marttila, U. Rinne, V. Sonninen, 1991, Acta neurologica Scandinavica.

Dopaminergic nervous transmission in Parkinson's disease.

P. Riekkinen, U. Rinne, V. Sonninen, 1974, Medical biology.

L-deprenyl treatment of on-off phenomena in Parkinson's disease

U. Rinne, V. Sonninen, T. Siirtola, 2005, Journal of Neural Transmission.

A Double Blind Study of l-Dopa Treatment in Parkinson's Disease

U. Rinne, V. Sonninen, 1968 .

The occurrence of dopamine and noradrenaline in the tubero-hypophysial system

U. Rinne, V. Sonninen, 1968, Experientia.

Urinary Excretion of 3,4-Dimethoxyphenylethylamine in Parkinson's Disease

U. Rinne, V. Sonninen, 1967, Nature.

Acid monoamine metabolites in cerebrospinal fluid in multiple sclerosis

U. Rinne, V. Sonninen, P. Riekkinen, 1973, Neurology.

Long-term responses of Parkinson's disease to levodopa therapy.

R. Marttila, U. Rinne, V. Sonninen, 1980, Journal of neural transmission. Supplementum.

Excretion of vanilmandelic and homovanillic acids in man during oxypertine treatment

U. Rinne, V. Sonninen, 2004, Psychopharmacologia.

Urinary excretion of monoamines and their metabolites in patients with Parkinson's disease Response to long-term treatment with levodopa alone or in combination with a dopa decarboxylase inhibitor and clinical correlations

U. Rinne, V. Sonninen, T. Siirtola, 1975, Clinical Neurology and Neurosurgery.

CORTICOTROPHIN TREATMENT IN MULTIPLE SCLEROSIS

U. Rinne, T. Tuovinen, V. Sonninen, 1968, Acta neurologica Scandinavica.

Corticotrophin treatment in multiple sclerosis.

U. Rinne, T. Tuovinen, V. Sonninen, 1968, Acta neurologica Scandinavica.

The occurrence of dopamine and noradrenaline in the tubero-hypophysial system.

U. Rinne, V. Sonninen, 2009, Acta neurologica Scandinavica.

Ultrastructural Alterations and Changes in the Catecholamine Content of the Neurosecretory Nerve Endings in the Median Eminence of the Rat after Oxypertine Injection

H. Helminen, U. Rinne, V. Sonninen, 1967 .

DIURNAL CHANGES IN THE HYPOTHALAMO-NEUROHYPOPHYSIAL NEUROSECRETION OF THE RAT AND ITS RELATION TO THE RELEASE OF CORTICOTROPHIN.

U. Rinne, V. Sonninen, 1964, Acta anatomica.

Acid monoamine metabolites in the cerebrospinal fluid of Parkinsonian patients treated with levodopa alone or combined with a decarboxylase inhibitor.

U. Rinne, V. Sonninen, T. Siirtola, 1973, European neurology.

Brain dopamine turnover and the relief of parkinsonism.

R. Marttila, U. Rinne, V. Sonninen, 1977, Archives of neurology.

Interaction between dopamine and phospholipids. Studies of the substantia nigra in Parkinson disease patients.

P. Riekkinen, U. Rinne, T. Pelliniemi, 1975, Archives of neurology.

Effect of L-dopa on brain monoamines and their metabolites in Parkinson's disease.

M. Hyyppä, U. Rinne, V. Sonninen, 1971, Life sciences. Pt. 1: Physiology and pharmacology.

GABA receptor binding in the parkinsonian brain.

V. Koskinen, P. Lönnberg, U. Rinne, 1978, Life sciences.

On the effect of amantadine on monoamines and their metabolites in the brain and cerebrospinal fluid

M. Hyyppä, U. Rinne, V. Sonninen, 1972, Experientia.

Levodopa in Parkinson's disease: effect on mortality

R. Marttila, U. Rinne, V. Sonninen, 1984 .

Mortality of patients with parkinson's disease treated with levodopa

R. Marttila, U. Rinne, V. Sonninen, 1977, Journal of Neurology.

Plasma testosterone content of male patients with Parkinson's disease during L-dopa treatment with or without dopadecarboxylase inhibitor.

R. Salokangas, U. Rinne, V. Sonninen, 1972, Acta neurologica Scandinavica. Supplementum.

EXCRETION OF FREE AND CONJUGATED 5‐HIAA AND VMA IN URINE AND CONCENTRATION OF 5‐HIAA AND HVA IN CSF DURING MIGRAINE ATTACKS AND FREE INTERVALS

U. Rinne, V. Sonninen, P. Kangasniemi, 1972, Headache.

BRAIN ACETYLCHOLINESTERASE IN PARKINSON'S DISEASE

P. Riekkinen, U. Rinne, V. Sonninen, 1973, Acta neurologica Scandinavica.

Cathepsin C activity as related to some histochemical substrates

G. Glenner, T. Vanha-Perttula, V. Sonninen, 1965, Histochemie.